Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial

The effects of tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, on weight reduction after successful intensive lifestyle intervention are unknown. This double-blind, placebo-controlled trial randomized (1:1) adults with body mass index ≥30 or...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadden, Thomas A., Chao, Ariana M., Machineni, Sriram, Kushner, Robert, Ard, Jamy, Srivastava, Gitanjali, Halpern, Bruno, Zhang, Shuyu, Chen, Jiaxun, Bunck, Mathijs C., Ahmad, Nadia N., Forrester, Tammy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667099/
https://www.ncbi.nlm.nih.gov/pubmed/37840095
http://dx.doi.org/10.1038/s41591-023-02597-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667099/
https://www.ncbi.nlm.nih.gov/pubmed/37840095
http://dx.doi.org/10.1038/s41591-023-02597-w

Ejemplares similares